Updated on 3 September 2025
Q-Velox Fully Automated PCR Diagnostic System
About
Q-Velox is a fully automated, real-time PCR based molecular diagnostic system with all-in-one disposable cartridge. The fully enclosed cartridge contains an unique sample preparation system and a separate reaction chamber, and comes with all reagents pre-loaded on board. Completely automated sample preparation and real-time quantitative PCR reaction and detection are performed by the Q-Velox, reducing operator hands-on time, reducing time to results, eliminating human error and cross-contamination, and improving test accuracy.
Project Location
- China
Project Format
- Private Project
ESG (Environmental, Social, and Governance)
- No
Project Stage
- Operations
Main Project Sector
- Technology
Technology
- Bio-Tech
- Health Technology
- Medical Technology
Total Project Value
- 25,000,001 to 50,000,000 USD
Investment Capital Required
- 500,001 to 1,000,000 USD
Interested Format of Cooperation
- Joint Venture
- Minority Shareholdings
- Open for Negotiation
- Public–private partnership / Concession
- R&D Cooperation
Preferred Financing Model
- Equity
- Open for negotiation
Previous Funding Stage
- Series B
Main Service(s) Required
- Financial Services
- Professional Services
Financial Services
- Institutional Investment
- Mergers & Acquisition
- Private Equity & Venture Capital
Professional Services
- Financial Advisory
- Market Entry Strategic Analysis
Attached files
Organisation
Serilink Biotechnology Company Limited
Hong Kong, China (Hong Kong)
Similar opportunities
Project
Equity investment project /opportunity: Turning Wineries into AI-Powered DTC Leaders
- Yes
- Equity
- Operations
- Technology
- E-Business
- Trust Fund
- Joint Venture
- Private Project
- Private Banking
- Financial Services
- Equal Shareholdings
- Series C and beyond
- Open for Negotiation
- Mergers & Acquisition
- Majority Shareholdings
- Minority Shareholdings
- Supply Chain Technology
- Institutional Investment
- 1,000,001 to 2,500,000 USD
- 10,000,001 to 25,000,000 USD
- Private Equity & Venture Capital
Sara Cheng
Managing Director at Channel One Au
Sydney, Australia
Project
Unsupervised AI - Series B 无监督人工智能 - B轮融资
- No
- Equity
- Fin-Tech
- Series A
- Operations
- Technology
- Private Project
- Financial Services
- Equal Shareholdings
- Open for Negotiation
- Mergers & Acquisition
- Minority Shareholdings
- 50,000,001 USD or above
- Institutional Investment
- 7,500,001 to 10,000,000 USD
- Private Equity & Venture Capital
Polly Siu
Global Financial Services at GlobalOne Capital Consulting Limited 世恩资本顾问有限公司
Hong Kong, China (Hong Kong)
Project
- No
- Equity
- Series B
- Operations
- Technology
- E-Business
- 100% Takeover
- Joint Venture
- Private Project
- Financial Services
- Open for Negotiation
- Open for negotiation
- Majority Shareholdings
- Minority Shareholdings
- 5,000,001 to 7,500,000 USD
- 5,000,001 to 7,500,000 USD
Flora Mok
Director, M&A at BlueMount Capital (Qld) Pty Ltd
Brisabne, Australia